RenovoRx (RNXT) EPS (Basic) Growth (5y) (2025 - 2026)

RenovoRx (RNXT) EPS (Basic) Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.83 Bn	130.98 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.79 Bn	77.79 Bn	3.93 Bn
3	Argenx Se	64.95 Bn	59.77 Bn	1.37 Bn
4	Moderna	58.59 Bn	53.46 Bn	52.00 Mn
5	BeOne Medicines	41.93 Bn	36.83 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.52 Bn	28.21 Bn	992.69 Mn
7	BioNTech SE	27.98 Bn	9.58 Bn	668.28 Mn
8	Insmed	27.42 Bn	26.26 Bn	358.27 Mn
9	Royalty Pharma	27.33 Bn	26.49 Bn	-
10	RenovoRx	62.20 Mn	62.20 Mn	766,000.00

Download Data